Differing Presentations of Excess Visceral Abdominal Fat in People Living With HIV: Two Clinical Cases Highlighting Distinct Therapeutic Pathways With Tesamorelin and Glucagon-Like Peptide-1 Receptor Agonists

Case report published in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2026) covering Tesamorelin.

Case report.

The record

• Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 82(Supplement_4): S87-S91
• Published: 2026-05-15
• PMID: 42139091 — DOI: 10.1093/cid/ciag121
• MeSH terms: Humans, HIV Infections, Body Mass Index, Adult, Middle Aged, Female, Male, Intra-Abdominal Fat, Growth Hormone-Releasing Hormone, Obesity, Abdominal, Glucagon-Like Peptide-1 Receptor Agonists
• Funding: Theratechnologies
• Author countries: Canada, USA

Peptide profiles: Tesamorelin.

All indexed evidence: Tesamorelin trials & papers.

Related studies: Tesamorelin as an Adjunct to Exercise for Improving Physical Function in HIV (TRIUMPH):….